Opiranserin (VVZ-149) is a novel non-opioid, non-steroidal intravenous analgesic with triple antagonistic activity at glycine transporter 2 (GlyT2), purine 2 receptor 3 (P2X3), and serotonin receptor (5-HT2A). Its half-maximal inhibitory …
Study Finds THC-CBD Marijuana Extracts Linked to Reduced Pain and Opioid Use in Women With Endometriosis The Marijuana Herald
Study Finds THC-CBD Marijuana Extracts Linked to Reduced Pain and Opioid Use in Women With Endometriosis themarijuanaherald.com
Endometriosis is a chronic gynecological disorder characterized by persistent pain and impaired quality of life, with limited effective treatment options. Emerging evidence indicates that cannabinoids may provide analgesic and symptom-relieving …
Relugolix is an oral, non-peptide gonadotropin-releasing hormone receptor antagonist administered as once-daily combination therapy (relugolix-CT; 40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate) to reduce endometriosis symptoms while …
Endometriosis and irritable bowel syndrome (IBS) are chronic pain disorders that frequently coexist and share key pathophysiological features, including neuroinflammation, visceral hypersensitivity, peripheral sensitization, and central sensitization. Emerging evidence suggests …
Opioids Carry Risks Without Treating Lesion Biology streamlinefeed.co.ke
Medical Marijuana Improves Pain, Sleep And Anxiety In Women With Endometriosis While Also Reducing Opioid Use, Study Shows Marijuana Moment
Study: Medical Cannabis Associated With Sustained Endometriosis Pain Relief and Lower Opioid Use Over Two Years The Marijuana Herald
Deep infiltrative endometriosis involving the bowel is a complex disease in which the optimal minimally invasive surgical approach remains uncertain, particularly regarding long-term fertility, recurrence, and healthcare utilization. We conducted …